Терапия синдрома «сухого глаза», развившегося после воспалительных заболеваний роговицы

@inproceedings{2020,
  title={Терапия синдрома «сухого глаза», развившегося после воспалительных заболеваний роговицы},
  author={И. А. Гндоян and А. В. Петраевский},
  year={2020}
}
Purpose : evaluation of the efficacy of the drug Tealose® in the therapy of cornea inflammatory diseases consequences such as dry eye syndrome. Patients and methods : 34 patients (34 eyes) with dry eye syndrome after inflammatory diseases of the cornea, aged 28–56 years old were included in the study. Two clinical groups were formed: observation group — 20 subjects (20 eye) and comparison group — 14 subjects (14 eyes). The dynamics of such indicators were estimated under therapy: visual acuity… CONTINUE READING

References

SHOWING 1-10 OF 20 REFERENCES
Preservatives in eyedrops: The good, the bad and the ugly
  • 602
  • PDF
Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas.
  • N. Burstein
  • Biology, Medicine
  • Investigative ophthalmology & visual science
  • 1980
  • 171